Anti-Integrin alpha 2 antibody [EPR17349]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Integrin alpha 2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CD49b, CD49B, ITGA2, Integrin alpha-2, CD49 antigen-like family member B, Collagen receptor, Platelet membrane glycoprotein Ia, VLA-2 subunit alpha, GPIa
- IP
Supplier Data
Immunoprecipitation - Anti-Integrin alpha 2 antibody [EPR17349] (AB181549)
Integrin alpha 2 was immunoprecipitated from 0.35 mg of A549 (Human lung carcinoma cell line) whole cell lysate with ab181549 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab181549 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : A549 whole cell lysate, 10μg (Input).
Lane 2 : ab181549 IP in A549 whole cell lysate.
Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab181549 in A549 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-Integrin alpha 2 antibody [EPR17349] (ab181549)
Predicted band size: 129 kDa
false
- WB
Supplier Data
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (AB181549)
Blocking/Dilution buffer : 5% NFDM/TBST.
The increased of molecular weight is due to glycosylation and is consistent with what has been described in the literature (PMID : 10825287 & 22354032).
All lanes:
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (ab181549) at 1/5000 dilution
All lanes:
Human skin lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 129 kDa
Observed band size: 150 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (AB181549)
Blocking/Dilution buffer : 5% NFDM/TBST.
The increased of molecular weight is due to glycosylation and is consistent with what has been described in the literature (PMID : 10825287 & 22354032).
All lanes:
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (ab181549) at 1/1000 dilution
Lane 1:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
A431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 3:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 129 kDa
Observed band size: 150 kDa
false
Exposure time: 30s
- WB
Lab
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (AB181549)
Lanes 1-4 : Merged signal (red and green). Green - ab181549 observed at 160 kDa. Red - loading control ab8245 observed at 37 kDa.
ab181549 Anti-Integrin alpha 2 antibody [EPR17349] was shown to specifically react with Integrin alpha 2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264819 (knockout cell lysate ab257262) was used. Wild-type and Integrin alpha 2 knockout samples were subjected to SDS-PAGE. ab181549 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 Dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (ab181549) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ITGA2 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human ITGA2 (CD49b) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-itga2-cd49b-knockout-hela-cell-line-ab264819'>ab264819</a>)
Lane 3:
A431 cell lysate at 20 µg
Lane 4:
K562 cell lysate at 20 µg
Predicted band size: 129 kDa,130 kDa,171 kDa
Observed band size: 160 kDa,250 kDa
false
- WB
Lab
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (AB181549)
Lanes 1 - 3 : Merged signal (red and green). Green - ab181549 observed at 160 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab181549 was shown to specifically recognize ITGA2 in wild-type HAP1 cells in addition to additional cross-reactive bands. No band was observed when ITGA2 knockout samples were examined. Wild-type and ITGA2 knockout samples were subjected to SDS-PAGE. ab181549 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (ab181549) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
ITGA2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
A431 whole cell lysate at 20 µg
Predicted band size: 129 kDa
false
- WB
Supplier Data
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (AB181549)
Blocking/Dilution buffer : 5% NFDM/TBST.
The increased of molecular weight is due to glycosylation and is consistent with what has been described in the literature (PMID : 10825287 & 22354032).
All lanes:
Western blot - Anti-Integrin alpha 2 antibody [EPR17349] (ab181549) at 1/1000 dilution
All lanes:
Human kidney lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 129 kDa
Observed band size: 150 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-Integrin alpha 2 antibody [EPR17349] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Integrin alpha 2 plays a significant role in cellular processes like migration and proliferation. It forms a heterodimer complex by pairing with the beta 1-integrin subunit contributing to its adhesive and signaling functions. This association enables the integrin alpha 2 complex to bind specific extracellular matrix components such as collagen and laminin. Through these interactions it regulates processes like wound healing and tissue remodeling and affects how cells respond to mechanical stress.
Pathways
Integrin alpha 2 is involved in major signaling routes that influence cell fate and movement. Notably it participates in the PI3K/AKT and MAPK pathways which are important for regulating cell growth and survival. It interacts with signaling proteins like focal adhesion kinase (FAK) and Src family kinases linking extracellular matrix changes to intracellular responses. These pathways help in transmitting signals that coordinate the cell's structural and functional adjustments in response to its surroundings.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
British journal of pharmacology 182:3649-3668 PubMed40222951
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com